Longitudinal plasma proteomic analysis identifies biomarkers and combinational targets for anti-PD1-resistant cancer patientsQiaoyun Tan, Yuankai Shi, Ruyun Gao et al.|Cancer Immunology Immunotherapy|2024Cited by 10